Infants and Toddlers at Highest Risk of Severe Outcomes from Multiple Viruses
With the COVID, flu and RSV tripledemic, new research spotlights the effects of COVID-19 variants and multiple viruses on young patients.
Tag: RSV respiratory syncytial virus
All
Latest
All
Latest
FDA Authorizes First COVID-Flu-RSV Test Without a Prescription
The US FDA authorized use of the Labcorp Seasonal Respiratory Virus RT-PCR DTC Test -- the first COVID-Flu-RSV test without the need for a prescription.
All
Latest
FDA OK’s Fast Track Status to mRNA RSV Vaccine
The FDA has granted Fast Track designation to Moderna's investigational single-dose mRNA-1345 vaccine against the respiratory syncytial virus (RSV) for people over 60 years of age.
New RSV Vaccine Shows Strong Immune Response
An experimental vaccine against respiratory syncytial virus (RSV), one of the leading causes of...
Read More
Johnson & Johnson to Write-off $900M RSV Fail
Johnson & Johnson is scrapping its investigational therapy for respiratory syncytial virus (RSV) and human metapneumovirus to the tune of a $900 million tax write-off.
Read More
RSV Takes a Greater Toll on Infants Under 2
New research suggests that respiratory syncytial virus (RSV) burden for infants under age 2 was 1.5-fold greater than previously believed.
Read MoreMaternal Vaccine for RSV on the Horizon
A team of investigators at Novavax Inc are at the cusp of the revolutionary development of a maternal vaccine for respiratory syncytial virus (RSV). The Maryland-based clinical-stage vaccine company intends to share data in the...
Read More
Clinical Trial for RSV Vaccine Underway
A Phase 1 study will examine the safety of an experimental intranasal vaccine and its ability to induce an immune response to respiratory syncytial virus (RSV).
Read More
Phase 3 Trial of RSV Vaccine Continues
RSV F is a respiratory syncytial virus F protein recombinant nanoparticle vaccine for infants via maternal immunization.
Read More
Respiratory Syncytial Virus Linked with CV Complications
Respiratory syncytial virus (RSV) can increase risk of cardiovascular complications for individuals with and without preexisting cardiovascular disease.
Read More
Pregnant Moms Can Transmit RSV to Unborn Child, Alter Immunity
Pregnant women infected with respiratory syncytial virus (RSV) can transmit the bug from their respiratory tract to the lungs of their unborn baby – resulting in altered immunity development after birth.
Read More
RSV Outbreak Hits Denver Hospital
The Rocky Mountain Hospital for Children in Denver is currently “packed with children” suffering from respiratory syncytial virus (RSV).
Read More
New RSV Drug Shows Positive Results
A phase 2a challenge study for GS-5806, an investigational oral RSV fusion inhibitor, found that the drug safely reduced the viral load and clinical illness of healthy adult volunteers who were intranasally infected with respiratory syncytial virus.
Read More
Bubble CPAP – Cost Effective, Efficient, and Safe
New devices are continuing the life-saving impact of bubble CPAP technology, which, since 1973, has saved thousands of newborns with severe respiratory illnesses.
Read More
Can Ginseng Treat, Prevent Influenza and RSV?
Through trials with mice, researchers believe red ginseng extract improves the survival of human lung epithelial cells infected with the influenza A virus.
Read More